Medicare Enrolled

Dr. Sherif El-Masry, MD

Urology Physician · Yonkers, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
127 S BROADWAY, Yonkers, NY 10701
9143787000
In practice since 2006 (20 years)
NPI: 1588611685 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. El-Masry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Masry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. El-Masry

Dr. Sherif El-Masry is an urology physician in Yonkers, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. El-Masry performed 56,179 Medicare services across 2,561 unique beneficiaries.

Between the years covered by Open Payments, Dr. El-Masry received a total of $2,036 from 16 pharmaceutical and/or device companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. El-Masry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in NY $2,036 industry payments

Medicare Practice Summary

Medicare Utilization ↗
56,179
Medicare services
Top 1% in NY for urology physician
2,561
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,809 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
50,000 $0 $0
Lidocaine HCl injection for IV infusion, 10 mg
Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion.
1,690 $0 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
999 $75 $200
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
792 $3 $25
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
499 $8 $20
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
343 $13 $100
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
332 $10 $50
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
245 $12 $150
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
225 $50 $300
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
148 $0 $30
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
146 $219 $475
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
146 $121 $300
Leuprolide acetate (for depot suspension), 7.5 mg 138 $134 $1,000
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
88 $31 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
67 $137 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
64 $105 $250
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
64 $0 $30
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
31 $145 $450
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
30 $22 $600
Ultrasound of penis artery and vein blood flow
An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis.
25 $104 $500
Transvaginal pelvic ultrasound
An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures.
22 $105 $200
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
19 $304 $800
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
16 $536 $1,800
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
13 $330 $700
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
13 $30 $460
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
13 $185 $500
Prostate tissue destruction using microwave heat
This procedure destroys prostate tissue by applying heat generated through microwave energy.
11 $1,343 $5,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
91.5% medium
5.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,036
Total received (2018-2024)
Avg $339/year across 6 years
Bottom 49% in NY for urology physician
16
Companies
33
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,045 (51.3%)
Other
Charitable contributions, space rental, and other categories
$543 (26.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$448 (22.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$678
2023
$389
2022
$236
2021
$389
2019
$26
2018
$317

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Olympus America Inc.
$543
Axonics, Inc.
$135
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus America Inc.
$561
Astellas Pharma US Inc
$307
Axonics, Inc.
$234
Progenics Pharmaceuticals, Inc.
$125
IDORSIA PHARMACEUTICALS US INC
$125
UROVANT SCIENCES INC
$125
AstraZeneca Pharmaceuticals LP
$121
Janssen Products, LP
$99
Janssen Biotech, Inc.
$88
PFIZER INC.
$85
Janssen Scientific Affairs, LLC
$83
Sumitomo Pharma America, Inc.
$26
ABBVIE INC.
$15
Myriad Genetic Laboratories, Inc.
$15
AbbVie Inc.
$15
Cumberland Pharmaceuticals, Inc.
$12
Top 3 companies account for 54.1% of all-time payments
Associated products mentioned in payments ›
BREZTRI · Bulkamid · CYSTO-NEPHRO VIDEOSCOPE · Caldolor · Erleada · GEMTESA · LUPRON DEPOT · MYRBETRIQ · MYRISK · Olympus GI Accessories · PYLARIFY · QUVIVIQ · XTANDI · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Yonkers?
Compare urology physicians in the Yonkers area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
718
Per 100K population
72.0
County median income
$118,411
Nearest hospital
ST JOSEPH'S MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. El-Masry is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. El-Masry experienced with testosterone injection?
Based on Medicare claims data, Dr. El-Masry performed 50,000 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Masry receive payments from pharmaceutical companies?
Yes. Dr. El-Masry received a total of $2,036 from 16 companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Masry's costs compare to other urology physicians in Yonkers?
Dr. El-Masry's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Masry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →